Global Telehealth Market
Global telehealth market will reach $171.13 billion by 2030, growing by 20.5% annually over 2020- ... Read More
Table of Contents 1 Introduction 6 1.1 Industry Definition and Research Scope 6 1.1.1 Industry Definition 6 1.1.2 Research Scope 7 1.2 Research Methodology 10 1.2.1 Overview of Market Research Methodology 10 1.2.2 Market Assumption 11 1.2.3 Secondary Data 11 1.2.4 Primary Data 11 1.2.5 Data Filtration and Model Design 13 1.2.6 Market Size/Share Estimation 14 1.2.7 Research Limitations 15 1.3 Executive Summary 16 2 Market Overview and Dynamics 19 2.1 Market Size and Forecast 19 2.1.1 Impact of COVID-19 on World Economy 20 2.1.2 Impact of COVID-19 on the Market 23 2.2 Major Growth Drivers 25 2.3 Market Restraints and Challenges 30 2.4 Emerging Opportunities and Market Trends 33 2.5 Porter’s Fiver Forces Analysis 37 3 Segmentation of Asia Pacific Market by Service 41 3.1 Market Overview by Service 41 3.2 CRO for Pre-clinical Development 43 3.3 CRO for Phase I Trials 44 3.4 CRO for Phase II Trials 45 3.5 CRO for Phase III Trials 46 3.6 CRO for Phase IV Trials 47 3.7 Laboratory Services 48 3.8 Consulting Services 49 3.9 Data Management Services 50 4 Segmentation of Asia Pacific Market by Therapeutic Application 51 4.1 Market Overview by Therapeutic Application 51 4.2 Infectious Diseases 53 4.3 Oncology 54 4.4 Metabolic Disorders 55 4.5 Cardiovascular Disorders 56 4.6 Central Nervous System 57 4.7 Respiratory Disorders 58 4.8 Gastrointestinal Disorders 59 4.9 Other Therapeutic Applications 60 5 Segmentation of Asia Pacific Market by End User 61 5.1 Market Overview by End User 61 5.2 Pharmaceutical & Biopharmaceutical Companies 63 5.3 Medical Device Companies 64 5.4 Academic Institutes 65 6 Asia-Pacific Market 2019-2030 by Country 67 6.1 Overview of Asia-Pacific Market 67 6.2 Japan 70 6.3 China 73 6.4 Australia 75 6.5 India 77 6.6 South Korea 80 6.7 Rest of APAC Region 82 7 Competitive Landscape 84 7.1 Overview of Key Vendors 84 7.2 New Product Launch, Partnership, Investment, and M&A 88 7.3 Company Profiles 89 Charles River Laboratories 89 CMIC Co. Ltd 91 Covance Inc. 92 Hangzhou Tigermed Consulting Co Ltd 93 ICON Plc 94 IQVIA Holdings Inc. 95 LSK Asia Pacific Pharma Service Co Ltd 96 Novotech Pty Ltd 97 PAREXEL International Corporation 98 Pharmaceutical Product Development LLC (PPD) 99 PRA Health Sciences Inc. 100 Quanticate Ltd 101 Samsung Bioepis Co. Ltd 102 SGS SA (SGS Life Sciences) 103 Syneos Health Inc. 104 WuXi AppTec Inc. 105 8 Investing in Asia Pacific Market: Risk Assessment and Management 106 8.1 Risk Evaluation of Asia Pacific Market 106 8.2 Critical Success Factors (CSFs) 109 Related Reports and Products 112
Table 1. Snapshot of Asia Pacific Pharmaceutical CRO Market in Balanced Perspective, 2019-2030 17 Table 2. Growth Rate of World Real GDP, 2017-2021 21 Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn 27 Table 4. Worldwide Total Number of Registered Clinical Trials 29 Table 5. Main Product Trends and Market Opportunities in Asia Pacific Pharmaceutical CRO Market 33 Table 6. Asia Pacific Pharmaceutical CRO Market by Service, 2019-2030, $ bn 41 Table 7. Asia Pacific Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 51 Table 8. Asia Pacific Pharmaceutical CRO Market by End User, 2019-2030, $ bn 61 Table 9. APAC Pharmaceutical CRO Market by Country, 2019-2030, $ bn 68 Table 10. Japan Pharmaceutical CRO Market by Service, 2019-2030, $ bn 72 Table 11. Japan Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 72 Table 12. Japan Pharmaceutical CRO Market by End User, 2019-2030, $ bn 72 Table 13. China Pharmaceutical CRO Market by Service, 2019-2030, $ bn 74 Table 14. China Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 74 Table 15. China Pharmaceutical CRO Market by End User, 2019-2030, $ bn 74 Table 16. Australia Pharmaceutical CRO Market by Service, 2019-2030, $ bn 76 Table 17. Australia Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 76 Table 18. Australia Pharmaceutical CRO Market by End User, 2019-2030, $ bn 76 Table 19. India Pharmaceutical CRO Market by Service, 2019-2030, $ bn 79 Table 20. India Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 79 Table 21. India Pharmaceutical CRO Market by End User, 2019-2030, $ bn 79 Table 22. South Korea Pharmaceutical CRO Market by Service, 2019-2030, $ bn 81 Table 23. South Korea Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 81 Table 24. South Korea Pharmaceutical CRO Market by End User, 2019-2030, $ bn 81 Table 25. Pharmaceutical CRO Market in Rest of APAC by Country, 2019-2030, $ bn 83 Table 26. Breakdown of Asia Pacific Market by Key Vendor, 2019, % 86 Table 27. Charles River Laboratories: Company Snapshot 89 Table 28. Charles River Laboratories: Business Segmentation 89 Table 29. Charles River Laboratories: Product Portfolio 90 Table 30. Charles River Laboratories: Revenue, 2016-2018, $ bn 90 Table 31. Charles River Laboratories: Recent Developments 90 Table 32. Risk Evaluation for Investing in Asia Pacific Market, 2019-2030 107 Table 33. Critical Success Factors and Key Takeaways 110
Figure 1. Research Method Flow Chart 10 Figure 2. Breakdown of Primary Research 12 Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 14 Figure 4. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 16 Figure 5. Asia Pacific Pharmaceutical CRO Market, 2019-2030, $ bn 19 Figure 6. Impact of COVID-19 on Business 23 Figure 7. Primary Drivers and Impact Factors of Asia Pacific Pharmaceutical CRO Market 25 Figure 8. Primary Restraints and Impact Factors of Asia Pacific Pharmaceutical CRO Market 30 Figure 9. Investment Opportunity Analysis 34 Figure 10. Porter’s Fiver Forces Analysis of Asia Pacific Pharmaceutical CRO Market 37 Figure 11. Breakdown of Asia Pacific Pharmaceutical CRO Market by Service, 2019-2030, % of Sales Revenue 42 Figure 12. Asia Pacific Addressable Market Cap in 2020-2030 by Service, Value ($ bn) and Share (%) 42 Figure 13. Asia Pacific Pharmaceutical CRO Market: CRO for Pre-clinical Development, 2019-2030, $ bn 43 Figure 14. Asia Pacific Pharmaceutical CRO Market: CRO for Phase I Trials, 2019-2030, $ bn 44 Figure 15. Asia Pacific Pharmaceutical CRO Market: CRO for Phase II Trials, 2019-2030, $ bn 45 Figure 16. Asia Pacific Pharmaceutical CRO Market: CRO for Phase III Trials, 2019-2030, $ bn 46 Figure 17. Asia Pacific Pharmaceutical CRO Market: CRO for Phase IV Trials, 2019-2030, $ bn 47 Figure 18. Asia Pacific Pharmaceutical CRO Market: Laboratory Services, 2019-2030, $ bn 48 Figure 19. Asia Pacific Pharmaceutical CRO Market: Consulting Services, 2019-2030, $ bn 49 Figure 20. Asia Pacific Pharmaceutical CRO Market: Data Management Services, 2019-2030, $ bn 50 Figure 21. Breakdown of Asia Pacific Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, % of Sales Revenue 52 Figure 22. Asia Pacific Addressable Market Cap in 2020-2030 by Therapeutic Application, Value ($ bn) and Share (%) 52 Figure 23. Asia Pacific Pharmaceutical CRO Market: Infectious Diseases, 2019-2030, $ bn 53 Figure 24. Asia Pacific Pharmaceutical CRO Market: Oncology, 2019-2030, $ bn 54 Figure 25. Asia Pacific Pharmaceutical CRO Market: Metabolic Disorders, 2019-2030, $ bn 55 Figure 26. Asia Pacific Pharmaceutical CRO Market: Cardiovascular Disorders, 2019-2030, $ bn 56 Figure 27. Asia Pacific Pharmaceutical CRO Market: Central Nervous System, 2019-2030, $ bn 57 Figure 28. Asia Pacific Pharmaceutical CRO Market: Respiratory Disorders, 2019-2030, $ bn 58 Figure 29. Asia Pacific Pharmaceutical CRO Market: Gastrointestinal Disorders, 2019-2030, $ bn 59 Figure 30. Asia Pacific Pharmaceutical CRO Market: Other Therapeutic Applications, 2019-2030, $ bn 60 Figure 31. Breakdown of Asia Pacific Pharmaceutical CRO Market by End User, 2019-2030, % of Revenue 62 Figure 32. Asia Pacific Addressable Market Cap in 2020-2030 by End User, Value ($ bn) and Share (%) 62 Figure 33. Asia Pacific Pharmaceutical CRO Market: Pharmaceutical & Biopharmaceutical Companies, 2019-2030, $ bn 63 Figure 34. Asia Pacific Pharmaceutical CRO Market: Medical Device Companies, 2019-2030, $ bn 64 Figure 35. Asia Pacific Pharmaceutical CRO Market: Academic Institutes, 2019-2030, $ bn 65 Figure 36. Breakdown of APAC Pharmaceutical CRO Market by Country, 2019 and 2030, % of Revenue 68 Figure 37. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 69 Figure 38. Pharmaceutical CRO Market in Japan, 2019-2030, $ bn 71 Figure 39. Pharmaceutical CRO Market in China, 2019-2030, $ bn 73 Figure 40. Pharmaceutical CRO Market in Australia, 2019-2030, $ bn 75 Figure 41. Pharmaceutical CRO Market in India, 2019-2030, $ bn 77 Figure 42. Pharmaceutical CRO Market in South Korea, 2019-2030, $ bn 80 Figure 43. Pharmaceutical CRO Market in Rest of APAC, 2019-2030, $ bn 82 Figure 44. Growth Stage of Asia Pacific Pharmaceutical CRO Industry over the Forecast Period 84
Key Players (this may not be a complete list and extra companies can be added upon request): Charles River Laboratories CMIC Co. Ltd Covance Inc. Hangzhou Tigermed Consulting Co Ltd ICON Plc IQVIA Holdings Inc. LSK Global Pharma Service Co Ltd Novotech Pty Ltd PAREXEL International Corporation Pharmaceutical Product Development LLC (PPD) PRA Health Sciences Inc. Quanticate Ltd Samsung Bioepis Co. Ltd SGS SA (SGS Life Sciences) Syneos Health Inc. WuXi AppTec Inc.
Global telehealth market will reach $171.13 billion by 2030, growing by 20.5% annually over 2020- ... Read More
North America telehealth market is expected to grow by 20.0% annually in the forecast period and ... Read More
Europe telehealth market accounted for $6,185.4 million in 2019 and will grow by 18.9% annually o ... Read More
Asia Pacific telehealth market will grow by 24.8% annually with a total addressable market cap of ... Read More